https://journals.asm.org/doi/10.1128/mbio.02472-22

>new antifungal compound, solanimycin, produced by a hybrid polyketide/nonribosomal peptide (PKS/NRPS) system in Dickeya solani,the enterobacterial pathogen of potato. Solanimycin was active against abroad range of plant-pathogenic fungi of global economic concern andthe human pathogen Candida albicans.

https://en.wikipedia.org/wiki/Candida_albicans#Role_in_disease

>Candida is found worldwide but most commonly compromises immunocompromised individuals diagnosed with serious diseases such as HIV and cancer. Candida are ranked as one of the most common groups of organisms that cause hospital-acquired infections. Especially high-risk individuals are patients that have recently undergone surgery, a transplant or are in the Intensive Care Units (ICU),[75] C. albicans infections is the top source of fungal infections in critically ill or otherwise immuncompromised patients.[76]